Therapeutic Potential of Selenium Compounds in the Treatment of Cancer
Authors:
Open Access
- 25 October 2018
- book chapter
- Published by Springer Nature
- p. 251-269
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signalingCellular Signalling, 2012
- Chemopreventive mechanisms of α-keto acid metabolites of naturally occurring organoselenium compoundsAmino Acids, 2010
- Cysteine S-conjugate β-lyases: important roles in the metabolism of naturally occurring sulfur and selenium-containing compounds, xenobiotics and anticancer agentsAmino Acids, 2010
- Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1αCancer Chemotherapy and Pharmacology, 2010
- Structure, expression, and function of kynurenine aminotransferases in human and rodent brainsCellular and Molecular Life Sciences, 2009
- Extracellular thiol-assisted selenium uptake dependent on the x c − cystine transporter explains the cancer-specific cytotoxicity of seleniteProceedings of the National Academy of Sciences, 2009
- -Keto acid metabolites of organoselenium compounds inhibit histone deacetylase activity in human colon cancer cellsCarcinogenesis, 2009
- Substrate specificity of human glutamine transaminase K as an aminotransferase and as a cysteine S-conjugate β-lyaseArchives of Biochemistry and Biophysics, 2008
- Subchronic oral toxicity studies of Se-methylselenocysteine, an organoselenium compound for breast cancer preventionFood and Chemical Toxicology, 2008
- High affinity selenium uptake in a keratinocyte modelFEBS Letters, 2007